Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

In Rehab, journalist Shoshana Walter investigates the systemic pitfalls of drug treatment programs, which prevent people’s recovery from addiction.

Guillain-Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be expected to benefit. To examine the ability of ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is frustrated by the delay of approved treatments in the rare disease ...

The drug, elamipretide, targets cardiolipins, a molecule in the mitochondria that is a key source for the gene defect. It’s the only drug for Barth Syndrome clinical trials.

Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a ...

In 2016, we have seen a rapid emergence of Zika virus-associated Guillain-Barré syndrome (GBS) since its first description in a French-Polynesian patient in 2014. Current evidence estimates the ...

To elucidate the features of patients with Guillain-Barré syndrome who show markedly rapid clinical recovery, clinical, serological, and electrophysiological data of 80 consecutive patients were ...